Roger Jeffs is President at UNITED THERAPEUTICS CORP (UTHR). They have made 11 open-market trades across 5 companies since 2006, most recently 2026-07-13.
CIK 0001231615
8 open-market purchases totalling $4.3M since 2017, against 3 sales. Across 8 scored buys the stock is up 22.1% at ninety days, and 18.8 points ahead of the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 63% | 63% | 50% |
| Avg Move | +11.1% | +8.7% | +22.1% |
| Alpha | +9.8% | +8.4% | +18.8% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LQDA | SELL · 10b5-1 | 2026-07-13 | 2026-07-14 | $71.51 | $2.5M | +13.3% | -5.3% | -63.7% |
| AXSM | SELL · 10b5-1 | 2026-06-10 | 2026-06-11 | $247.65 | $142K | -6.7% | -10.6% | -17.5% |
| LQDA | SELL · 10b5-1 | 2026-05-27 | 2026-05-28 | $62.18 | $400K | +3.8% | +21.7% | +15.6% |
| LQDA | SELL · 10b5-1 | 2026-05-21 | 2026-05-26 | $61.01 | $4.6M | +2.5% | +27.6% | +16.6% |
| LQDA | SELL · 10b5-1 | 2026-05-18 | 2026-05-20 | $58.91 | $4.4M | -9.3% | +24.2% | +22.3% |
| LQDA | SELL · 10b5-1 | 2026-05-13 | 2026-05-15 | $57.32 | $4.3M | +7.3% | +24.1% | +24.7% |
| LQDA | SELL · 10b5-1 | 2026-05-08 | 2026-05-12 | $45.89 | $3.4M | +8.6% | +27.6% | +62.3% |
| LQDA | SELL · 10b5-1 | 2026-05-05 | 2026-05-07 | $40.99 | $3.1M | +43.3% | +52.7% | +113.2% |
| LQDA | SELL · 10b5-1 | 2026-04-17 | 2026-04-21 | $40.60 | $765K | +5.9% | +71.9% | +114.0% |
| LQDA | SELL · 10b5-1 | 2026-04-14 | 2026-04-16 | $40.21 | $2.1M | -9.1% | +37.6% | +87.7% |
| LQDA | SELL · 10b5-1 | 2026-04-10 | 2026-04-14 | $39.06 | $2.1M | -4.1% | +52.2% | +83.2% |
| LQDA | SELL · 10b5-1 | 2026-04-09 | 2026-04-13 | $40.12 | $1.0M | -3.2% | +48.8% | +84.2% |
| LQDA | SELL · 10b5-1 | 2026-01-12 | 2026-01-13 | $37.43 | $2.5M | +10.2% | +1.9% | +1.4% |
| LQDA | SELL · 10b5-1 | 2025-10-13 | 2025-10-15 | $23.41 | $949K | -2.3% | +20.3% | +63.5% |
| AXSM | SELL · 10b5-1 | 2025-09-02 | 2025-09-02 | $123.68 | $3.3M | -4.1% | -2.9% | +20.7% |
| AXSM | SELL · 10b5-1 | 2025-08-27 | 2025-08-29 | $121.72 | $7.3M | +1.3% | -3.1% | +24.8% |
| AXSM | SELL · 10b5-1 | 2025-08-22 | 2025-08-26 | $120.06 | $6.4M | +6.7% | -4.3% | +24.8% |
| LQDA | SELL · 10b5-1 | 2025-07-14 | 2025-07-15 | $14.28 | $578K | +34.6% | +79.2% | +63.3% |
| LQDA | SELL · 10b5-1 | 2025-06-04 | 2025-06-05 | $16.97 | $1.0M | -25.5% | -31.7% | +60.2% |
| LQDA | SELL · 10b5-1 | 2025-04-14 | 2025-04-16 | $13.57 | $383K | -1.5% | +37.6% | +5.8% |
| LQDA | SELL · 10b5-1 | 2025-01-14 | 2025-01-14 | $11.78 | $526K | +21.5% | +40.0% | +19.9% |
| LQDA | SELL · 10b5-1 | 2024-10-14 | 2024-10-15 | $11.11 | $179K | -5.2% | -13.7% | +1.3% |
| LQDA | SELL · 10b5-1 | 2024-07-12 | 2024-07-15 | $12.53 | $202K | -10.1% | +7.8% | -12.7% |
| LQDA | SELL · 10b5-1 | 2024-04-12 | 2024-04-16 | $14.58 | $244K | -6.8% | -5.2% | -7.4% |
| LQDA | SELL · 10b5-1 | 2024-03-18 | 2024-03-19 | $15.82 | $904K | -6.8% | -13.7% | -16.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.